Ticker
INBXCompany Name
INHIBRX BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Financing |
---|---|
6/30/2025 | $ 99.84M |
3/31/2025 | $ 132.79M |
12/31/2024 | $ 71.68M |
12/31/2023 | $ 201.96M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Dec 31, 2024
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.23K |
---|---|
min | $ -367.1M |
max | $ 366M |
average | $ -6.74M |
median | $ 314K |
std | $ 119.11M |